Building La Dolce Vita with Science

Research collaboration between the National Institutes of Health and the Istituto Superiore di Sanità (ISS) began with the signing of a Letter of Intent at the end of July. This institutional agreement confirms a Memorandum of Understanding for greater US-Italian cooperation in health and medical science signed on April 1. The partnership is designed to promote research areas of mutual interest, including cancer, cardiovascular disease, pulmonary disease, women's health, and neuroscien

Written byChris Berrie
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Research collaboration between the National Institutes of Health and the Istituto Superiore di Sanità (ISS) began with the signing of a Letter of Intent at the end of July. This institutional agreement confirms a Memorandum of Understanding for greater US-Italian cooperation in health and medical science signed on April 1. The partnership is designed to promote research areas of mutual interest, including cancer, cardiovascular disease, pulmonary disease, women's health, and neuroscience.

The project attracted the attention of key US and Italian science leaders. And as a declaration of high scientific interest, two Nobel Prize laureates, Rita Levi Montalcini (1986) and Paul Greengard (2000), witnessed the July proceedings.

THE MONEY Although the finer details remain undisclosed, the Italian Minister of Health, Girolamo Sirchia, is providing ¤10 million to ISS President Enrico Garaci, to be used for research proposals involving "cooperative activities undertaken or implemented by the ISS." Of particular note, this ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies